RAB31 and neoplasm: Dysregulated expression of Rab31 has been observed in benign conditions, such as skin diseases, but is also involved in multiple aspects of tumor progression in various types of cancer, including breast, ovarian, cervical and liver cancer as well as glioblastoma (for a review see [Kotzsch et al. 2016]).